'Pretty dramatic:' Everything you need to know about the COVID-19 pill from Merck

New Jersey-based pharmaceutical company Merck & Co. says a recent study shows they have an experimental pill that reduced hospitalizations and deaths by half in people who are newly infected with COVID-19. They are planning to ask for emergency use authorization for the treatment. Dr. Angie Nicholas and Dr. Darren Mareiniss with Einstein Medical Center say the pill is a potential game changer. They join the podcast to explain what the pill does, who can benefit from taking it, and when it could be available.